Investigating Novel Wee1 and Chk1 Inhibitors with Improved Brain Permeability for the Treatment of Glioblastoma

Project: Research

Project Details

Description

SULSA-industrial collaboration evaluating novel brain permeable compounds in 3D glioblastoma model systems
StatusFinished
Effective start/end date1/09/2231/08/23

Funding

  • Sentinel Oncology Limited
  • Scottish Funding Council SFC: £15,000.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.